Test my supply
53%
Finnrick rating
#294 of 301 ranked vendors
7 of 29 classifiable tests passed
methodology · Purity focus
Finnrick analysis

Deuschem's purity-focus record is split, with Melanotan II and Semaglutide the relative bright spots while Ipamorelin and Tirzepatide are driven by repeated identity or fill failures. Evidence is recent but narrow and batch-concentrated, so the signal looks consistent within problem lots rather than broadly proven across the catalog.

methodology →
vendor intelligence report
Vendor Intelligence Report: Deuschem

Deuschem is verified by Deus Medical, but its storefront omits the legal counterparty while a corporate-record trail points to a small Indian private company. The report maps the offshore domain shift, removed review profile, affiliate codes and phantom-tracking complaints.

31 pages8 risk factors assessed2 Jul 2026
read the report
Peptides
#
Peptide
$/MG
Rating
N
1
Melanotan II
$3.10
72%
4
2
Semaglutide
$20.20
70%
4
3
Tirzepatide
$10.10
69%
4
4
Ipamorelin
$10.50
50%
5
5
PT-141
$3.10
44%
4
6
BPC-157
$7.20
41%
4
7
CJC-1295
$15.50
21%
4
Contact channels
Rating trend
CUMULATIVE FINNRICK RATING
83%+65%+48%+30%+<30%13 Jun 2025: 34%13 Jun 2025: 49%13 Jun 2025: 48%14 Jun 2025: 53%14 Jun 2025: 54%16 Jun 2025: 48%16 Jun 2025: 49%25 Jun 2025: 49%25 Jun 2025: 48%25 Jun 2025: 48%26 Jun 2025: 49%26 Jun 2025: 48%27 Jun 2025: 48%27 Jun 2025: 48%29 Jun 2025: 48%29 Jun 2025: 47%29 Jun 2025: 47%29 Jun 2025: 47%29 Jun 2025: 47%29 Jun 2025: 46%29 Jun 2025: 46%4 Aug 2025: 45%4 Aug 2025: 45%4 Aug 2025: 44%4 Aug 2025: 44%4 Aug 2025: 45%5 Aug 2025: 44%5 Aug 2025: 43%6 Nov 2025: 43%10 Aug 2026: current 53%34%43%53%Jun 25Aug 26
Test my supply
Deuschem test history
COA-backed lab tests
DateResultTestLabPurityDosageLabelCOA
6 Nov 2025Fail
Ipamorelin
lab nameView COA
5 Aug 2025Fail
Semaglutide
lab nameView COA
5 Aug 2025Fail
Tirzepatide
lab nameView COA
4 Aug 2025Pass
Melanotan II (Astera labs)
lab nameView COA
4 Aug 2025Fail
CJC-1295 (DAC)
lab nameView COA
4 Aug 2025Fail
BPC-157
lab nameView COA
4 Aug 2025Fail
PT-141
lab nameView COA
4 Aug 2025Fail
Ipamorelin
lab nameView COA
29 Jun 2025Fail
BPC-157
lab nameView COA
29 Jun 2025Fail
Tirzepatide
lab nameView COA
1-10 of 29

About Deuschem test results from Finnrick

Deuschem is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 7 peptides and 29 tests, including ratings, observed price signals, recent test dates, and correction history where available.

Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.

The most visible Deuschem peptides in this dataset are Melanotan II (4 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.

Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 29 recent tests.

Corrections
No corrections.
Test my supply